share_log

JMP Securities Maintains Market Outperform on Benitec Biopharma, Raises Price Target to $6

JMP Securities Maintains Market Outperform on Benitec Biopharma, Raises Price Target to $6

JMP Securities维持Benitec Biopharma的跑赢大盘,目标股价上调至6美元
Benzinga ·  2023/09/26 09:01

JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the price target from $4 to $6.

JMP Securities分析师Silvan Tuerkcan维持Benitec Biopharma(纳斯达克股票代码:BNTC)的市场跑赢大盘,并将目标股价从4美元上调至6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发